Recent studies have found that depleted levels of ApoA1 might may a role in the pathophysiology of various neurodegenerative disorders, such as Alzheimer’s disease (Lin et al., 2015) and depression (Morris et al., 2021). This evidence concerns the gene APOA1 and early-onset autosomal dominant Alzheimer disease.